{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:13:31Z","timestamp":1787238811326,"version":"build-2736575974"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human-induced pluripotent stem cell (hiPSC) technologies have provided access to in vitro models of inaccessible human cardiomyocytes (CMs), providing new insights into human disease mechanisms, therapy strategies, and cardiac toxicology. However, the robustness of reproducible outcomes and integration of data among research groups are hampered due to the variation between cell lines, clones, and batches-to-batch differences. These variable outcomes in hiPSC models are caused by differences in human donors, genetic stability, and experimental variability, which affect morphology, cellular heterogeneity, transcript and protein abundance, and differentiation potency. This review summarizes the usage of hiPSC-CMs obtained from multiple lines and evaluates the corresponding experimental variation between studies to perform in-depth in vitro power calculations. Our meta-analyses show that although 4 or more hiPSC lines are used in 21 published case-control studies, these reports still contain high heterogeneity between functional parameters. In specific CM readouts, the SD is &amp;gt;40%, meaning that the variation between different cell lines is larger than the effect of the studied mutation, drug response, or toxicity. Results indicate a need for careful selection of hiPSC lines, controls, and readout stability and these insights will further guide the power of hiPSC lines in biomedical applications.<\/jats:p>","DOI":"10.1093\/stcltm\/szag001","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:46:44Z","timestamp":1767790004000},"source":"Crossref","is-referenced-by-count":3,"title":["Heterogeneity and optimal study design between cell lines in induced pluripotent stem cell-based cardiac disease modeling"],"prefix":"10.1093","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6607-4104","authenticated-orcid":false,"given":"Renee G C","family":"Maas","sequence":"first","affiliation":[{"name":"Utrecht Regenerative Medicine Center, Circulatory Health Research Center, University Utrecht , Utrecht, 3584 CS,","place":["The Netherlands"]},{"name":"Experimental Cardiology Laboratory, Department of Cardiology, Division Heart and Lung, University Medical Center Utrecht , Utrecht, 3584 CX,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0802-8617","authenticated-orcid":false,"given":"Chris","family":"Denning","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Biology, Biodiscovery Institute, University of Nottingham , Nottingham, NG7 2RD,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2088-9102","authenticated-orcid":false,"given":"Joost P G","family":"Sluijter","sequence":"additional","affiliation":[{"name":"Utrecht Regenerative Medicine Center, Circulatory Health Research Center, University Utrecht , Utrecht, 3584 CS,","place":["The Netherlands"]},{"name":"Experimental Cardiology Laboratory, Department of Cardiology, Division Heart and Lung, University Medical Center Utrecht , Utrecht, 3584 CX,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"2026021523265784700_szag001-B1","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/cvr\/cvy208","article-title":"Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential","volume":"114","author":"van Mil","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2026021523265784700_szag001-B2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093404","article-title":"Modeling cardiovascular diseases with hiPSC-derived cardiomyocytes in 2D and 3D cultures","volume":"21","author":"Sacchetto","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026021523265784700_szag001-B3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s11886-022-01683-8","article-title":"Modeling nonischemic genetic cardiomyopathies using induced pluripotent stem cells","volume":"24","author":"Khedro","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"2026021523265784700_szag001-B4","doi-asserted-by":"crossref","first-page":"100334","DOI":"10.1016\/j.xpro.2021.100334","article-title":"Massive expansion and cryopreservation of functional human induced pluripotent stem cell-derived cardiomyocytes","volume":"2","author":"Maas","year":"2021","journal-title":"STAR Protoc"},{"key":"2026021523265784700_szag001-B5","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1093\/eurheartj\/ehae519","article-title":"Clinical trials in-a-dish for cardiovascular medicine","volume":"45","author":"Wu","year":"2024","journal-title":"Eur Heart J"},{"key":"2026021523265784700_szag001-B6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jacbts.2019.02.005","article-title":"Phase II trials in drug development and adaptive trial design","volume":"4","author":"Van Norman","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"2026021523265784700_szag001-B7","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175824","article-title":"FDA modernization act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches","volume":"133","author":"Zushin","year":"2023","journal-title":"J Clin Invest"},{"key":"2026021523265784700_szag001-B8","first-page":"139","volume-title":"Chapter 4 - Probability, Introductory Statistics (Fourth Edition)","author":"Ross","year":"2017"},{"key":"2026021523265784700_szag001-B9","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/ndt\/gfp732","article-title":"Sample size calculations: basic principles and common pitfalls","volume":"25","author":"Noordzij","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"2026021523265784700_szag001-B10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.vascn.2018.09.002","article-title":"Challenges in designing and executing clinical trials in a dish studies","volume":"94","author":"Fermini","year":"2018","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2026021523265784700_szag001-B11","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.stem.2020.05.004","article-title":"Human-iPSC-derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease","volume":"26","author":"Giacomelli","year":"2020","journal-title":"Cell Stem Cell"},{"key":"2026021523265784700_szag001-B12","doi-asserted-by":"crossref","first-page":"106367","DOI":"10.1016\/j.cmpb.2021.106367","article-title":"On computational classification of genetic cardiac diseases applying iPSC cardiomyocytes","volume":"210","author":"Juhola","year":"2021","journal-title":"Comput Methods Programs Biomed"},{"key":"2026021523265784700_szag001-B13","doi-asserted-by":"crossref","first-page":"103582","DOI":"10.1016\/j.scr.2024.103582","article-title":"Patient-derived induced pluripotent stem cells to study non-canonical splicing variants associated with hypertrophic cardiomyopathy","volume":"81","author":"Jager","year":"2024","journal-title":"Stem Cell Res"},{"key":"2026021523265784700_szag001-B14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179808","article-title":"Bioenergetic and metabolic impairments in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients","volume":"23","author":"Willi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026021523265784700_szag001-B15","doi-asserted-by":"crossref","first-page":"130ra47","DOI":"10.1126\/scitranslmed.3003552","article-title":"Patient-specific induced pluripotent stem cell as a model for familial dilated cardiomyopathy","volume":"4","author":"Sun","year":"2012","journal-title":"Sci Transl Med"},{"key":"2026021523265784700_szag001-B16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.stem.2012.10.010","article-title":"Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells","volume":"12","author":"Lan","year":"2013","journal-title":"Cell Stem Cell"},{"key":"2026021523265784700_szag001-B17","doi-asserted-by":"crossref","first-page":"1077069","DOI":"10.3389\/fphys.2022.1077069","article-title":"Action potential variability in human pluripotent stem cell-derived cardiomyocytes obtained from healthy donors","volume":"13","author":"Carvalho","year":"2022","journal-title":"Front Physiol"},{"key":"2026021523265784700_szag001-B18","doi-asserted-by":"crossref","first-page":"778982","DOI":"10.3389\/fphys.2021.778982","article-title":"Phenotypic variability in iPSC-induced cardiomyocytes and cardiac fibroblasts carrying diverse mutations","volume":"12","author":"Yang","year":"2021","journal-title":"Front Physiol"},{"key":"2026021523265784700_szag001-B19","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/CIRCULATIONAHA.119.039521","article-title":"Cronos titin is expressed in human cardiomyocytes and necessary for normal sarcomere function","volume":"140","author":"Zaunbrecher","year":"2019","journal-title":"Circulation"},{"key":"2026021523265784700_szag001-B20","doi-asserted-by":"crossref","first-page":"9276","DOI":"10.1073\/pnas.1714538115","article-title":"Telomere shortening is a hallmark of genetic cardiomyopathies","volume":"115","author":"Chang","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026021523265784700_szag001-B21","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.stemcr.2020.09.002","article-title":"Comparison of 10 control hPSC lines for drug screening in an engineered heart tissue format","volume":"15","author":"Mannhardt","year":"2020","journal-title":"Stem Cell Reports"},{"key":"2026021523265784700_szag001-B22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10439-020-02521-0","article-title":"Analysis of drug effects on iPSC cardiomyocytes with machine learning","volume":"49","author":"Juhola","year":"2021","journal-title":"Ann Biomed Eng"},{"key":"2026021523265784700_szag001-B23","doi-asserted-by":"crossref","first-page":"106598","DOI":"10.1016\/j.vascn.2019.106598","article-title":"HiPSC-CMs from different sex and ethnic origin donors exhibit qualitatively different responses to several classes of pharmacological challenges","volume":"99","author":"Zeng","year":"2019","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2026021523265784700_szag001-B24","doi-asserted-by":"crossref","first-page":"107531","DOI":"10.1016\/j.vascn.2024.107531","article-title":"Bayesian approach enabled objective comparison of multiple human iPSC-derived cardiomyocytes\u2019 proarrhythmia sensitivities","volume":"128","author":"Wakatsuki","year":"2024","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2026021523265784700_szag001-B25","doi-asserted-by":"crossref","first-page":"e1011164","DOI":"10.1371\/journal.pgen.1011164","article-title":"Anthracyclines induce cardiotoxicity through a shared gene expression response signature","volume":"20","author":"Matthews","year":"2024","journal-title":"PLoS Genet"},{"key":"2026021523265784700_szag001-B26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.stemcr.2016.12.014","article-title":"Recapitulation of clinical individual susceptibility to drug-induced QT prolongation in healthy subjects using iPSC-derived cardiomyocytes","volume":"8","author":"Shinozawa","year":"2017","journal-title":"Stem Cell Reports"},{"key":"2026021523265784700_szag001-B27","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.19406","article-title":"Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells","volume":"6","author":"Stillitano","year":"2017","journal-title":"Elife"},{"key":"2026021523265784700_szag001-B28","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/cts.12674","article-title":"Clinical trial in a dish: personalized stem cell\u2013derived cardiomyocyte assay compared with clinical trial results for two QT-prolonging drugs","volume":"12","author":"Blinova","year":"2019","journal-title":"Clin Transl Sci"},{"key":"2026021523265784700_szag001-B29","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/scitranslmed.aaf2584","article-title":"High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells","volume":"9","author":"Sharma","year":"2017","journal-title":"Sci Transl Med"},{"key":"2026021523265784700_szag001-B30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.14573\/altex.1805301","article-title":"A human population-based organotypic in vitro model for cardiotoxicity screening","volume":"35","author":"Grimm","year":"2018","journal-title":"ALTEX"},{"key":"2026021523265784700_szag001-B31","doi-asserted-by":"crossref","first-page":"110643","DOI":"10.1016\/j.celrep.2022.110643","article-title":"Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons","volume":"39","author":"Huang","year":"2022","journal-title":"Cell Rep"},{"key":"2026021523265784700_szag001-B32","doi-asserted-by":"publisher","DOI":"10.3390\/ph15060765","article-title":"Cardio- and neurotoxicity of selected anti-COVID-19 drugs","author":"Nicholson","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"2026021523265784700_szag001-B33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/d41573-019-00074-z","article-title":"Trends in clinical success rates and therapeutic focus","volume":"18","author":"Dowden","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"2026021523265784700_szag001-B34","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.stem.2024.01.007","article-title":"Strengthening cardiac therapy pipelines using human pluripotent stem cell-derived cardiomyocytes","volume":"31","author":"Raniga","year":"2024","journal-title":"Cell Stem Cell"},{"key":"2026021523265784700_szag001-B35","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1111\/bph.13577","article-title":"Integrating cardiomyocytes from human pluripotent stem cells in safety pharmacology: has the time come?","volume":"174","author":"Sala","year":"2017","journal-title":"Br J Pharmacol"},{"key":"2026021523265784700_szag001-B36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nbt.3749","article-title":"Influence of donor age on induced pluripotent stem cells","volume":"35","author":"Lo Sardo","year":"2017","journal-title":"Nat Biotechnol"},{"key":"2026021523265784700_szag001-B37","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/s41380-022-01866-3","article-title":"Power and optimal study design in iPSC-based brain disease modelling","volume":"28","author":"Brunner","year":"2023","journal-title":"Mol Psychiatry"},{"key":"2026021523265784700_szag001-B38","doi-asserted-by":"publisher","first-page":"1308217","DOI":"10.3389\/fphar.2024.1308217","article-title":"iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity","volume":"15","author":"Lee","year":"2024","journal-title":"Front Pharmacol"},{"key":"2026021523265784700_szag001-B39","doi-asserted-by":"publisher","first-page":"dev201483","DOI":"10.1242\/dev.201483","article-title":"Harnessing developmental cues for cardiomyocyte production","volume":"150","author":"Maas","year":"2023","journal-title":"Development"},{"key":"2026021523265784700_szag001-B40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.113.003638","article-title":"J. Jalife extracellular matrix-mediated maturation of human pluripotent stem cell-derived cardiac monolayer structure and electrophysiological function circ","author":"Herron","year":"2016","journal-title":"Arrhythmia Electrophysiol"},{"key":"2026021523265784700_szag001-B41","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1126\/science.aaa5458","article-title":"Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy","volume":"349","author":"Hinson","year":"2015","journal-title":"Science"},{"key":"2026021523265784700_szag001-B42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chembiol.2021.02.016","article-title":"Human iPSC modeling of heart disease for drug development","volume":"28","author":"Hnatiuk","year":"2021","journal-title":"Cell Chem Biol"},{"key":"2026021523265784700_szag001-B43","author":"Maas","year":"2024"},{"key":"2026021523265784700_szag001-B44","doi-asserted-by":"publisher","first-page":"107925","DOI":"10.1016\/j.celrep.2020.107925","article-title":"Metabolic maturation media improve physiological function of human iPSC-derived cardiomyocytes","volume":"32","author":"Feyen","year":"2020","journal-title":"Cell Rep"},{"key":"2026021523265784700_szag001-B45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fcell.2020.00178","article-title":"A brief review of current maturation methods for human induced pluripotent stem cells-derived cardiomyocytes","volume":"8","author":"Ahmed","year":"2020","journal-title":"Front Cell Dev Biol"}],"container-title":["Stem Cells Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/15\/2\/szag001\/66612334\/szag001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/stcltm\/article-pdf\/15\/2\/szag001\/66612334\/szag001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T04:27:15Z","timestamp":1771216035000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/stcltm\/article\/doi\/10.1093\/stcltm\/szag001\/8443316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,26]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,1,26]]}},"URL":"https:\/\/doi.org\/10.1093\/stcltm\/szag001","relation":{},"ISSN":["2157-6564","2157-6580"],"issn-type":[{"value":"2157-6564","type":"print"},{"value":"2157-6580","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,26]]},"article-number":"szag001"}}